Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease
Open Access
- 1 October 1998
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (10), 1117-1122
- https://doi.org/10.1023/a:1008486928190
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.Journal of Clinical Oncology, 1997
- Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.Journal of Clinical Oncology, 1995
- The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patientsSeminars in Nuclear Medicine, 1995
- Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.Journal of Clinical Oncology, 1990
- Ga-67 SPECT before and after treatment of lymphoma.Radiology, 1990
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxideAmerican Journal of Roentgenology, 1989
- Staging laparotomy with splenectomy for Hodgkin's disease: The Stanford experienceWorld Journal of Surgery, 1985
- Gallium-67 scanning: Limited usefulness in staging patients with non-Hodgkin's lymphomaThe American Journal of Medicine, 1980
- Bone marrow manifestations of Hodgkin's diseaseCancer, 1976